In this blog post, Teresa Badillo explains why psychobiotics, which have the potential to regulate many of the neurotransmitters that affect emotions and mental-health functioning, may be helpful for those with mood disorders.
How often do we hear parents express their frustration of living with their moody teenage children? Anyone living with or working with teenagers can certainly identify. Parents learn to endure the rollercoaster ride knowing that eventually their teen will reach a more mature age and develop stability. But what if that doesn’t happen?
Today, the normal, neurotypical teenager:
- Struggles with having the ability to cope with unstable emotions
- Lacks the capacity to make good, sound decisions
- Does not have mind over matter
- Does not have the skillset to have good coping mechanisms
- May not be capable of self-soothing and self-regulation
It seems that everyone today, in every walk of life, struggles with mood issues. Just living and existing in our world of constant stress and anxiety makes it very difficult to regulate our mood and therefore, our nervous systems are often in the sympathetic-dominant, fight-or-flight mode instead of a more peaceful and relaxed rest-and-digest, parasympathetic mode. Navigating our stressful world with high anxiety only leads to emotional instability and more erratic mood swings.
Mood and the Vagus Nerve
What causes mood swings, mood disorders and mental health issues and why are these issues so prevalent today? According to Dr. Stephen Porges, the father of Polyvagal Theory, in his concept of neuroception, we are all in trauma mode as the body scans our environment for cues of safety or danger. According to Dr. Porges, not only does the body remember a traumatic experience, but it can get stuck in the trauma response and freezes. Mood regulation requires emotional stability. How do we regulate our emotions when we are living in fight or flight, constant fear, anxiety, stress, depression and trauma? How do we develop greater resiliency or learn to have better coping mechanisms to survive everyday living in our world today.
We don’t need to look very far. Many neurodegenerative and neurodevelopmental disorders such as autism spectrum disorders (ASD), Alzheimer’s disease and Parkinson’s disease all struggle with mood regulation. Research has finally understood that when the gut is not healthy, the brain is dramatically affected. We cannot begin to understand our mental-health functioning if we don’t look at how the body and brain work together simultaneously to function as one. One is not working without the other. Mood regulation is, therefore, dependent on both these two powerful forces: the brain and the body.
Let’s start with gut function. The vagus nerve, which is the transporter of gut bacteria to the brain from the gut, will be compromised and not function well under certain circumstances:
- Poor gut-brain axis
- Minimal diversity in the microbiome
- Neuroinflammation
- High cortisol levels
- Poor glycemic regulation
- Gastrointestinal inflammation
- Systemic Candida
- Parasites, viruses, bacteria
- Mycotoxins and biotoxins
All these conditions cause reduced vagus-nerve functioning and ultimately contribute to many mental health symptoms such as anxiety, depression and poor cognition.
Mood and the Microbiome
Mood is 100% dependent on a healthy microbiome. The microbiome is dependent on:
- A diverse diet rich in fiber from whole grains, fruits and vegetables
- High amounts of prebiotic-containing foods such as onions, lettuce, cabbage, apples, bananas
- Lots of good quality protein
- Fermented foods such as sauerkraut, kefir and kombucha
These foods, coupled with a strongly functioning vagus nerve, create a healthy gut-brain axis. This combination has a powerful positive effect on mood, behaviors, anxiety and depression. This outcome has led many mental health researchers to focus and do more neuroscience research in probiotics and certain strains of probiotics that can affect the gut microbiome-to-brain axis, with the intention of finding better viable solutions to ameliorate symptoms of mental health.
The autism community has been well versed in the gut-brain connection since the early 1990s, when autism rates were beginning to escalate in the United States and Canada. Parents of children with autism knew how important gut microbiome challenges were in maintaining a clean, healthy gut so that their children could reach their developmental milestones that they missed due to the onset of regressive autism under the age of three.
Dopamine and Serotonin
Two of the main issues for children with autism are gut dysbiosis and brain-chemistry imbalances in the neurotransmitters serotonin and dopamine, both of which have a profound effect on mood. Serotonin is a neurotransmitter that affects learning, memory, happiness as well as regulating body temperature, sleep, sexual behavior and hunger. Dopamine is a neurotransmitter affecting feelings of pleasure, satisfaction and motivation as well as controlling memory, sleep, learning, concentration and movement. Both neurotransmitters have a significant impact on brain function and mood.
For a child’s brain to function appropriately, a child needs to reach his or her developmental milestones in the normal timeframe. Many children with regressive autism experienced excessive toxicity either in the womb, at birth and/or before the age of three, causing their development to regress back in time to under one year of age and compromising their ability to reach their developmental milestones. Once neurodevelopment has regressed or been interrupted, it is very complicated and very specific to each child to regain their neurological functioning and their developmental milestones. It is difficult, but not impossible.
Psychobiotics
Giving these children specific strains of probiotics can have a beneficial effect on their gut microbiomes, which in turn can have a very powerful effect on their mood. A child with autism not treated biomedically will exhibit lots of inappropriate and maladaptive behaviors such as continual meltdowns, so the first place to start may be with the gut by giving the child specific probiotics and/or probiotic foods.
Today, researchers are looking at how probiotics and their long-term usage affect the central nervous system and the gastrointestinal system, and how they can improve mood swings, anxiety and depression in a person. Around 2013, the term “psychobiotics” came about due to some specific types of probiotics that had the potential of improving psychiatric symptoms.
Many mental health researchers (see Sources & References, below) became interested in specific probiotics with one or two strains of Lactobacillus or Bifidobacterium for their potential to be psychobiotics. These psychobiotics can regulate neurotransmitters such as GABA, serotonin, dopamine, glutamate and brain-derived neurotrophic factor (BDNF) that affect emotions and mental-health functioning. The bottom line for many professionals is that it is far healthier, safer and potentially just as effective to use psychobiotics as the first choice instead of SSRI drugs that may have potentially negative side effects. The key factor is that these neurotransmitters play important roles in controlling the neural excitatory-inhibitory balance (GABA/glutamate balance), mood, cognitive functions, learning and memory processes. Now psychobiotics have become a potentially viable option.
Researchers also found that psychobiotics also improve the function of the hypothalamic-pituitary-adrenal axis (HPA), which is the way our body responds to and deals with stress. Psychobiotics were also reported to inhibit inflammation and decrease cortisol levels, improve bowel motility, maintain gut lining integrity, encourage microbiome diversity and other contributing factors to successfully reduce symptoms of mood, anxiety and depression.
Neuralli
Recently, a new and potentially very effective psychobiotic has become available called Neuralli, which has been specifically designed for challenges such as autism spectrum disorders ASD, ADHD and Parkinson’s disease. Neuralli contains two clinically tested strains that influence the brain from the gut microbiome:
- Heat-treated Lactobacillus paracasei PS23 (HT-PS23) postbiotic
- Lactobacillus plantarum PS128 probiotic
Neuralli can potentially provide important benefits to children with autism. Many autism parents have reported improvements in:
- Sleep regulation
- Sensory integration
- Motor planning
- Mood regulation
- Trauma symptoms
- Restrictive eating disorders
- A more positive outlook on life
- Less anxiety
- Fewer meltdowns
- Improved ability to handle stress
- Improved socialization
- Increased motivation
Neuralli is providing the opportunity for many adults with ASD to improve their mood and stay consistent all day long. This opens the door for many possibilities with this population such as being able to maintain a job, living in a community, being able to function appropriately, needing less intervention, needing less drugs and so on. These adults can function throughout the day without experiencing the debilitating mood swings that negatively affect themselves, their loved ones and prohibit community participation because of too much aggression and even possible violence.
A psychobiotic such as Neuralli could be a positive solution for many families with older sons and daughters with ASD who need to keep a consistent happy mood to have better quality of life, maintain a job, keep a placement, live in the community and experience higher cognitive functioning at any age. It is possible.
About Teresa Badillo
In the 1980s she worked overseas in Rome, Italy at the Japanese Embassy in the office of the United Nations (FAO) as a speech writer. She also began her long journey in alternative healing while living in Rome.
After moving to New York and while raising her family of seven children, Teresa embarked on a mission to find alternative non-invasive biomedical, therapeutic, sensory and educational solutions for autism after the diagnosis of her son in the early 1990s.
She won a court case in 1995 against the Rockland County School District in New York to enable ARC Prime Time for Kids to be the first school using Applied Behavioral Analysis teaching method for autism that was paid for by the Rockland County School District. The following year she was instrumental in getting the New York Minister of Education to approve an extension of the ARC license from 5 to 21 years.
She has worked over the years in a number of alternative medical practices with doctors and practitioners organizing various biomedical intervention options for children with autism. Since the mid 1990s, Teresa has served on several boards:
- Foundation for Children with Developmental Disabilities
- The Autoimmunity Project
- Developmental Delayed Resources
- Epidemic Answers
She continues to consult and advise parents on all different areas of autism especially nutritional protocols. Since 2006 she has worked with NutraOrgana, LLC and BioCellular Analysis Testing. She currently researches, writes the newsletter and blogs Teresa’s Corner for The Autism Exchange (AEX). She also writes blog posts and pages for Documenting Hope.
Still Looking for Answers?
Visit the Epidemic Answers Practitioner Directory to find a practitioner near you.
Join us inside our online membership community for parents, Healing Together, where you’ll find even more healing resources, expert guidance, and a community to support you every step of your child’s healing journey.
Sources & References
Adams, J.B., et al. Gastrointestinal Flora and Gastrointestinal Status in Children with Autism—Comparisons to Typical Children and Correlation with Autism Severity. BMC Gastroenterol. 2011;11:22.
Aguilera, M., et al. Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice. Gut Microbes. 2015;6(1):10-23.
Appleton, J. The Gut-Brain Axis: Influence of Microbiota on Mood and Mental Health. Integr Med (Encinitas). 2018 Aug;17(4):28-32.
Arrieta, M.C., et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med. 2015 Sep 30;7(307):307ra152.
Aroniadis, O.C., et al. Fecal microbiota transplantation: past, present and future. Curr Opin Gastroenterol. 2013;29(1):79-84.
Assa, A., et al. Vitamin D deficiency promotes epithelial barrier dysfunction and intestinal inflammation. J Infect Dis. 2014;210(8):1296-305.
Atladóttir, H.Ó., et al. Autism after infection, febrile episodes, and antibiotic use during pregnancy: an exploratory study. Pediatrics. 2012 Dec;130(6):e1447-54.
Aversa, Z., et al. Association of Infant Antibiotic Exposure With Childhood Health Outcomes. Mayo Clin Proc. 2020 Nov 6;S0025-6196(20)30785-0.
Bäckhed, F., et al. Host-Bacterial Mutualism in the Human Intestine. Science. 2005 Mar 25;307(5717):1915-20.
Bennings, M.A., et al. Colonic transit times and behaviour profiles in children with defecation disorders. Archives of the Diseases of Childhood. 2004 Jan;89(1):13-6.
Berding, K., et al. Diet Can Impact Microbiota Composition in Children With Autism Spectrum Disorder. Front. Neurosci. 2018;12:515.
Bjørklund, G., et al. Gastrointestinal alterations in autism spectrum disorder: What do we know? Neurosci Biobehav Rev. 2020 Nov:118:111-120.
Bora, S.A., et al. Regulation of vitamin D metabolism following disruption of the microbiota using broad spectrum antibiotics. J Nutr Biochem. 2018 Jun;56:65-73.
Borchers, A.T., et al. Probiotics and immunity. Journal of Gastroenterology. 44 (2009): 26-46.
Borre, Y.E., et al. Microbiota and neurodevelopmental windows: implications for brain disorders.Trends Mol Med. 2014 Sep;20(9):509-18.
Bruzzese, E., et al. Disrupted intestinal microbiota and intestinal inflammation in children with cystic fibrosis and its restoration with Lactobacillus GG: a randomised clinical trial. PLoS One. 2014 Feb 19;9(2):e87796.
Buccigrossi, V., et al. Functions of intestinal microflora in children. Curr Opin Gastroenterol. 2013;29(1):31-8.
Buie, T., et al. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics. 2010 Jan;125 Suppl 1:S1-18.
Camilleri, M. Serotonin in the gastrointestinal tract. Curr Opin Endrocrinol Diabetes Obes. 2009 Feb;16(1):53-9.
Carding, S., et al. Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis. 2015;26:26191.
Chen, C.Q., et al. Distribution, function and physiological role of melatonin in the lower gut. World J Gastroenterol. 2011 Sep 14;17(34):3888-98.
Chen, Y., et al. Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders. Nutrients. 2021 Jun 19;13(6):2099.
Cheng, L.H., et al. Psychobiotics in mental health, neurodegenerative and neurodevelopmental disorders. J Food Drug Anal. 2019 Jul;27(3):632-648.
Clark, J.A., et al. Intestinal crosstalk—a new paradigm for understanding the gut as the ‘motor’ of critical illness. Shock.2007 Oct;28(4):384-93.
Cocean, A.M., et al. Exploring the gut-brain Axis: Potential therapeutic impact of Psychobiotics on mental health. Prog Neuropsychopharmacol Biol Psychiatry. 2024 Aug 30:134:111073.
Cohen-Mekelburg, S., et al. Morning light treatment for inflammatory bowel disease: a clinical trial. BMC Gastroenterol. 2024 May 22;24(1):179.
Correale, J., et al. The role of the gut microbiota in multiple sclerosis. Nat Rev Neurol. 2022 Sep;18(9):544-558.
Critchfield, et al. The potential role of probiotics in the management of childhood autism spectrum disorders. Gastroenterol Res Pract. 2011;2011:161358.
Cucchiara, S., et al. Interactions between intestinal microbiota and innate immune system in pediatric inflammatory bowel disease. J Clin Gastroenterol. 2012;46 Suppl:S64-6.
Cui, J., et al. Butyrate-Producing Bacteria and Insulin Homeostasis: The Microbiome and Insulin Longitudinal Evaluation Study (MILES). Diabetes. 2022 Nov 1;71(11):2438-2446.
da Costa Baptista, I.P., et al. Effect of the use of probiotics in the treatment of children with atopic dermatitis; a literature review. Nutr Hosp. 2013 Jan-Feb;28(1):16-26.
de Goffau, et al. Fecal microbiota composition differs between children with beta-cell autoimmunity and those without. Diabetes. 2013;62(4):1238-44.
D’Eufemia, P., et al. Abnormal intestinal permeability in children with autism. Acta Paediatr. 1996 Sep;85(9):1076-9.
de Magistris, et al. Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J Pediatr Gastroenterol Nutr. 2010;51(4):418-24.
Derrien, M., et al. The Gut Microbiota in the First Decade of Life. Trends Microbiol. 2019 Dec;27(12):997-1010.
Dhyani, P., et al. Psychobiotics for Mitigation of Neuro-Degenerative Diseases: Recent Advancements. Mol Nutr Food Res. 2024 Jul;68(13):e2300461.
Dinan, T.G., et al. The Microbiome-Gut-Brain Axis in Health and Disease. Gastroenterol Clin North Am. 2017 Mar;46(1):77-89.
Drago, L., et al. Changing of fecal flora and clinical effect of L. salivarius LS01 in adults with atopic dermatitis. J Clin Gastroenterol. 2012 Oct:46 Suppl:S56-63.
Dogra, S.K., et al. Gut Microbiota Resilience: Definition, Link to Health and Strategies for Intervention. Front Microbiol. 2020 Sep 15:11:572921.
Edwards, C.A., et al. Intestinal flora during the first months of life: new perspectives. British Journal of Nutrition. 88 (2002): S11-S18.
Erickson, C.A., et al. Gastrointestinal Factors in Autistic Disorder: A Critical Review. Journal of Autism and Developmental Disorders. 2005 Dec;35(6):713-27.
Etxeberria, U., et al. Reshaping faecal gut microbiota composition by the intake of trans-resveratrol and quercetin in high-fat sucrose diet-fed rats. J Nutr Biochem. 2015 Jun;26(6):651-60.
Fattorusso, A., et al. Autism Spectrum Disorders and the Gut Microbiota. Nutrients. 2019 Feb 28;11(3):521.
Feehley, T., et al. Healthy infants harbor intestinal bacteria that protect against food allergy. Nat Med. 2019 Mar;25(3):448-453.
Feng, P., et al. A review of probiotics in the treatment of autism spectrum disorders: Perspectives from the gut-brain axis. Front Microbiol. 2023 Mar 16:14:1123462.
Fujimura, K.E., et al. Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. Nat Med. 2016 Oct;22(10):1187-1191.
Fukuda, K., et al. Determination of the discriminant score of intestinal microbiota as a biomarker of disease activity in patients with ulcerative colitis. BMC Gastroenterol. 2014;14:49.
Galland, L. The gut microbiome and the brain. J Med Food 2014; 17(12): 1261-72.
Ganal-Vonarburg, S.C., et al. Microbial-host molecular exchange and its functional consequences in early mammalian life. Science. 2020 May 8;368(6491):604-607.
Gastrointestinal permeability in food-allergic children. Nutr Rev. 1985 Aug;43(8):233-5.
Grizotte-Lake, M., et al. Commensals Suppress Intestinal Epithelial Cell Retinoic Acid Synthesis to Regulate Interleukin-22 Activity and Prevent Microbial Dysbiosis. Immunity. 2018 Dec 18;49(6):1103-1115.e6.
Guandalini, S. Are probiotics or prebiotics useful in pediatric irritable bowel syndrome or inflammatory bowel disease? Front Med (Lausanne). 2014;1:23.
Guandalini, S., et al. Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children. Benef Microbes. 2015;6(2):209-17.
Hamad, A.F., et al. Prenatal antibiotics exposure and the risk of autism spectrum disorders: A population-based cohort study. PLoS One. 2019 Aug 29;14(8):e0221921.
Han, H., et al. Gut Microbiota and Type 1 Diabetes. Int J Mol Sci. 2018 Mar 27;19(4):995.
Hanaway, P. Balance of Flora, GALT, and Mucosal Integrity. Alternative Therapies in Health and Medicine. Sep-Oct 2006;12(5):52-60; quiz 61-2.
Hejitz, R.D., et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):3047-52.
Horn, J., et al. Role of Diet and Its Effects on the Gut Microbiome in the Pathophysiology of Mental Disorders. Transl. Psychiatry. 2022;12:164.
Horvath, K., et al. Autism and gastrointestinal symptoms. Curr Gastroenterol Rep. 2002 Jun;4(3):251-8.
Horvath, K., et al. Autistic disorder and gastrointestinal disease. Current Opinion in Pediatrics. 2002 Oct;14(5):583-7.
Horvath, K., et al. Gastrointestinal abnormalities in children with autistic disorder. Journal of Pediatrics. 1999 Nov;135(5):559-63.
Hrncir, T., et al. Gut microbiota and lipopolysaccharide content of the diet influence development of regulatory T cells: studies in germ-free mice. BMC Immunology. 9 (2008): 65.
Hyman, M.A. Is the Cure for Brain Disorders Outside the Brain? Alternative Therapies in Health and Medicine. Nov-Dec 2007;13(6):10-5.
Isaksson, J., et al. Brief Report: Association Between Autism Spectrum Disorder, Gastrointestinal Problems and Perinatal Risk Factors Within Sibling Pairs. J Autism Dev Disord. 2017 Aug;47(8):2621-2627.
Jackson, P.G., et al. Intestinal permeability in patients with eczema and food allergy. Lancet. 1981 Jun 13;1(8233):1285-6.
Jakobsen, C., et al. Environmental factors and risk of developing paediatric inflammatory bowel disease — a population based study. 2007-2009. J Crohns Colitis. 2013;7(1):79-88.
Jyonouchi, H., et al. Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention. Neuropsychobiology. 2005;51(2):77-85.
Jyonouchi, H., et al. Evaluation of an Association between Gastrointestinal Symptoms and Cytokine Production against Common Dietary Proteins in Children with Autism Spectrum Disorders. J. Pediatr. 2005;146:605–610.
Kang, D.W., et al. Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiota. Scientific Reports. 9, 5821 (2019).
Kang, D.W., et al. Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome.2017 Jan 23;5(1):10.
Karagözlü, S., et al. The Relationship of Severity of Autism with Gastrointestinal Symptoms and Serum Zonulin Levels in Autistic Children. J. Autism Dev. Disord. 2022;52:623–629.
Kaur, U.S., et al. High Abundance of genus Prevotella in the gut of perinatally HIV-infected children is associated with IP-10 levels despite therapy. Sci Rep. 2018 Dec 5;8(1):17679.
Kelly, J.R., et al. Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. Front Cell Neurosci. 2015 Oct 14;9:392.
Kim-Lee, C., et al. Gastrointestinal disease in Sjogren's syndrome: related to food hypersensitivities. Springerplus. 2015 Dec 12;4:766.
Ķimse, L., et al. A Narrative Review of Psychobiotics: Probiotics That Influence the Gut-Brain Axis. Medicina (Kaunas). 2024 Apr 5;60(4):601.
Kitano, H., et al. Robustness trade-offs and host-microbial symbiosis in the immune system. Molecular Systems Biology. 2 (2006).
Kobliner, V., et al. Reduction in Obsessive Compulsive Disorder and Self-Injurious Behavior With Saccharomyces boulardii in a Child with Autism: A Case Report. Integr Med (Encinitas). 2018 Dec;17(6):38-41.
Korpela, K., et al. Maternal Fecal Microbiota Transplantation in Cesarean-Born Infants Rapidly Restores Normal Gut Microbial Development: A Proof-of-Concept Study. Cell, 2020.
Lai, C.C.W., et al. The association between gut-health promoting diet and depression: A mediation analysis. J Affect Disord. 2023 Mar 1:324:136-142.
Larsen, J.M. The immune response to Prevotella bacteria in chronic inflammatory disease. Immunology. 2017 Aug;151(4):363-374.
Lavebratt, C., et al. Early exposure to antibiotic drugs and risk for psychiatric disorders: a population-based study. Transl Psychiatry. 2019 Nov 26;9(1):317.
Liu, Z., et al. Tight junctions, leaky intestines, and pediatric diseases. Acta Paediatricia. 94 (2005): 386-393.
Madra, M., et al. Gastrointestinal Issues and Autism Spectrum Disorder. Psychiatr Clin North Am. 2021 Mar; 44(1): 69–81.
Manichanh, C., et al. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol. 2012;9(10):599-608.
Mattila, K., et al. Burden of illness and use of health care services before and after celiac disease diagnosis in children. J Pediatr Gastroenterol Nutr. 2013;57(1):53-6
Mine, Y., et al. Surfactants Enhance the Tight-Junction Permeability of Food Allergens in Human Intestinal Epithelial Caco-2 Cells. International Archives of Allergy and Immunology. 2003 Feb;130(2):135-42.
Mitre, E., et al. Association Between Use of Acid-Suppressive Medications and Antibiotics During Infancy and Allergic Diseases in Early Childhood. JAMA Pediatr. 2018 Jun 4;172(6):e180315.
Mohan, R., et al. Effects of Bifidobacterium lactis Bb12 Supplementation on Intestinal Microbiota of Preterm Infants: A Double-Blind, Placebo-Controlled, Randomized Study. Journal of Clinical Microbiology. 2006 Nov;44(11):4025-31.
Möller, C., et al. Intestinal permeability as assessed with polyethyleneglycols in birch pollen allergic children undergoing oral immunotherapy. Allergy. 1986 May;41(4):280-5.
Montalto, M., et al. Fecal Calprotectin Concentrations in Patients with Small Intestinal Bacterial Overgrowth. Digestive Diseases.2008;26(2):183-6.
Morris, C.R., et al. Syndrome of allergy, apraxia, and malabsorption: characterization of a neurodevelopmental phenotype that responds to omega 3 and vitamin E supplementation. Alternative Therapies in Health and Medicine. Jul-Aug 2009;15(4):34-43.
Moser, L.A. Astrovirus Increases Epithelial Barrier Permeability Independently of Viral Replication. Journal of Virology. 2007 Nov;81(21):11937-45.
Nankova, B.B., et al. Enteric bacterial metabolites propionic and butyric acid modulate gene expression, including CREB-dependent catecholaminergic neurotransmission, in PC12 cells–possible relevance to autism spectrum disorders. PLoS One. 2014;9(8):e103740.
Nankova, B.B. Nicotinic Induction of Preproenkephalin and Tyrosine Hydroxylase Gene Expression in Butyrate-Differentiated Rat PC12 Cells: A Model for Adaptation to Gut-Derived Environmental Signals. Pediatric Research. 2003 Jan;53(1):113-8.
Nemechek, P., et al. Autism Spectrum Disorder Symptoms Improve with Combination Therapy Directed at Improving Gut Microbiota and Reducing Inflammation. Applied Psychiatry. 2020 Jul; (1)1.
Niederhofer, H., et al. A preliminary investigation of ADHD symptoms in persons with celiac disease. J Atten Disorder. 2006 Nov;10(2):200-4.
Nirmalkar, K., et al. Shotgun Metagenomics Study Suggests Alteration in Sulfur Metabolism and Oxidative Stress in Children with Autism and Improvement after Microbiota Transfer Therapy. Int J Mol Sci. 2022 Nov 3;23(21):13481.
Nikolova, V.L., et al. Acceptability, Tolerability, and Estimates of Putative Treatment Effects of Probiotics as Adjunctive Treatment in Patients With Depression. JAMA Psychiatry. 2023 Aug 1;80(8):842-847.
Nirmalkar, K., et al. Shotgun Metagenomics Study Suggests Alteration in Sulfur Metabolism and Oxidative Stress in Children with Autism and Improvement after Microbiota Transfer Therapy. Int J Mol Sci. 2022 Nov 3;23(21):13481.
O’Hara, A.M., et al. The gut flora as a forgotten organ. European Molecular Biology Organization Report 7, no 7 (July 2006): 688-693.
Oliva-Hemker, M., et al. Fecal Microbiota Transplantation: Information for the Pediatrician. Pediatrics. 2023 Dec 1;152(6):e2023062922.
Oroojzadeh, P., et al. Psychobiotics: the Influence of Gut Microbiota on the Gut-Brain Axis in Neurological Disorders. J Mol Neurosci. 2022 Sep;72(9):1952-1964.
Ozkul, C., et al. A single early-in-life antibiotic course increases susceptibility to DSS-induced colitis. Genome Med. 2020;12(1):65.
Parkin, K.,, et al. Risk Factors for Gut Dysbiosis in Early Life. Microorganisms. 2021 Sep 30;9(10):2066.
Pearson, A.D., et al. Intestinal permeability in children with Crohn's disease and coeliac disease. Br Med J (Clin Res Ed). 1982 Jul 3;285(6334):20-1.
Precup, G., et al. Gut Prevotella as a possible biomarker of diet and its eubiotic versus dysbiotic roles: a comprehensive literature review. Br J Nutr. 2019 Jul 28;122(2):131-140.
Rautava, S., et al. The Development of Gut Immune Responses and Gut Microbiota: Effects of Probiotics in Prevention and Treatment of Allergic Disease. Current Issues in Intestinal Microbiology. 2002 Mar;3(1):15-22.
Rediers, H., et al. Unraveling the Secret Lives of Bacteria: Use of In Vivo Expression Technology and Differential Fluorescence Induction Promoter Traps as Tools for Exploring Niche-Specific Gene Expression. Microbiology and Molecular Biology Reviews. 2005 Jun;69(2):217-61.
Relman, D.A. The human microbiome: ecosystem resilience and health. Nutr Rev. 2012 Aug;70 Suppl 1(Suppl 1):S2-9.
Ristori, M.V., et al. Autism, Gastrointestinal Symptoms and Modulation of Gut Microbiota by Nutritional Interventions. Nutrients. 2019;11:2812.
Rook, G.A., et al. Microbiota, immunoregulatory old friends and psychiatric disorders. Adv Exp Med Biol. 2014;817:319-56.
Rowland, I.R., et al. Effects of diet on mercury metabolism and excretion in mice given methylmercury: role of gut flora. Archives of Environmental Health. Nov-Dec 1984;39(6):401-8.
Sanchez, A., et al. Role of sugars in human neutrophilic phagocytosis. Am J Clin Nutr. 1973 Nov;26(11):1180-4.
Savino, F., et al. Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study. Pediatrics. 2007 Jan;119(1):e124-30.
Scirocco, A., et al. Exposure of Toll-like receptors 4 to bacterial lipopolysaccharide (LPS) impairs human colonic smooth muscle cell function. J Cell Physiol. 2010 May;223(2):442-50.
Sela, D.A., et al. The marriage of nutrigenomics with the microbiome: the case of infant associated bifidobacteria and milk. Am J Clin Nutr. 2014;99(3):697S-703S.
Severance, E.G., et al. IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophrenia. Brain Behav Immun. 2015 Feb;44:148-58.
Shao, Y., et al. Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth. Nature. 2019 Oct;574(7776):117-121.
Sharma, H., et al. Approach of probiotics in mental health as a psychobiotics. Arch Microbiol. 2021 Dec 19;204(1):30.
Shekhawat, P.S., et al. Spontaneous development of intestinal and colonic atrophy and inflammation in the carnitine-deficient jvs (OCTN2(-/-)) mice. Mol Genet Metab. 2007 Dec;92(4):315-24.
Sifroni, K.G., et al. Mitochondrial respiratory chain in the colonic mucosal of patients with ulcerative colitis. Mol Cell Biochem. 2010 Sep;342(1-2):111-5.
Simpson, C.A., et al. The gut microbiota in anxiety and depression - A systematic review. Clin Psychol Rev. 2021 Feb:83:101943.
Stewart, C.J., et al. Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature. 2018 Oct;562(7728):583-588.
Stokholm, J., et al. Delivery mode and gut microbial changes correlate with an increased risk of childhood asthma. Sci Transl Med. 2020 Nov 11;12(569):eaax9929.
Strauch, U.G., et al. Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis. Gut 54 (2005):1546-1552.
Strandwitz, P. Neurotransmitter Modulation by the Gut Microbiota. Brain Res. 2018 Aug 15;1693(Pt B):128-133.
Tobacman, J.K. Review of Harmful Gastrointestinal Effects of Carrageenan in Animal Experiments. Environmental Health Perspectives. 2001 Oct;109(10):983-94.
Torres, J., et al. Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice. Gut. 2020 Jan;69(1):42-51.
Tun, H.M., et al. Roles of Birth Mode and Infant Gut Microbiota in Intergenerational Transmission of Overweight and Obesity From Mother to Offspring. JAMA Pediatr. 2018 Apr 1;172(4):368-377.
Uhde, M., et al. Intestinal cell damage and systemic immune activation in individuals reporting sensitivity to wheat in the absence of coeliac disease. Gut. 2016 Dec;65(12):1930-1937.
Vael, C., et al. Early intestinal Bacteroides fragilis colonization and development of asthma. BMC Pulmonary Medicine. 2008 Sep 26;8:19.
van Nood, E., et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013 Jan 31;368(5):407-15.
Vatanen, T., et al. The human gut microbiome in early-onset type 1 diabetes from the TEDDY study. Nature. 2018 Oct;562(7728):589-594.
Videhult, F.K., et al. Impact of probiotics during weaning on the metabolic and inflammatory profile: follow-up at school age. Int J Food Sci Nutr. 2015;66(6):686-91.
Voigt, R.M., et al. The intestinal microbiota: determinants of resiliency? Lancet Healthy Longev. 2021 Jan;2(1):e2-e3.
Vojdani, A., et al. A Gut Feeling for Immune Dysregulation & Neuroinflammation in Autism. The Autism File. 2009(31).
Wang, J., et al. Global Prevalence of Autism Spectrum Disorder and Its Gastrointestinal Symptoms: A Systematic Review and Meta-Analysis. Front. Psychiatry. 2022;13:963102.
Warner, B.B. The contribution of the gut microbiome to neurodevelopment and neuropsychiatric disorders. Pediatr Res. 2019 Jan;85(2):216-224.
Wasilewska, J., et al. Gastrointestinal symptoms and autism spectrum disorder: links and risks – a possible new overlap syndrome. Pediatric Health Med Ther. 2015; 6: 153–166.
West, C.E., et al. The gut microbiota and inflammatory noncommunicable diseases: associations and potentials for gut microbiota therapies. J Allergy Clin Immunol. 2015;135(1):3-13; quiz 4.
Wexler, H. Bacteroides: the Good, the Bad, and the Nitty-Gritty. Clinical Microbiology Reviews 20, no. 4 (October 2007): 593-621.
White, E., et al. The Effect of Nutritional Therapy for Yeast Infection (Candidiasis) in Cases of Chronic Fatigue Syndrome. Journal of Orthomolecular Medicine. 2005;20(3).
Williams, B.L., et al. Impaired Carbohydrate Digestion and Transport and Mucosal Dysbiosis in the Intestines of Children with Autism and Gastrointestinal Disturbances. PLoS ONE. 2011;6:e24585.
Williams, R.E.O., et al. The influence of intestinal bacteria on the absorption and metabolism of foreign compounds. Journal of Clinical Pathology.1971; 5: 125–129.
Wilmanski, T., et al. Gut microbiome pattern reflects healthy ageing and predicts survival in humans. Nat Metab. 2021 Feb;3(2):274-286.
Wopereis, H., et al. Intestinal microbiota in infants at high risk for allergy: Effects of prebiotics and role in eczema development. J Allergy Clin Immunol. 2018 Apr;141(4):1334-1342.e5.
Yang, B., et al. Effects of regulating intestinal micobiota on anxiety symptoms: A systematic review. General Psychiatry. 2019; 32: e100056.
Yassour, M., et al. Strain-Level Analysis of Mother-to-Child Bacterial Transmission during the First Few Months of Life. Cell Host Microbe. 2018 Jul 11;24(1):146-154.e4.
Zheng, P., et al. Gut microbiome in type 1 diabetes: A comprehensive review. Diabetes Metab Res Rev. 2018 Oct;34(7):e3043.
Zhou, H., et al. Evaluating the Causal Role of Gut Microbiota in Type 1 Diabetes and Its Possible Pathogenic Mechanisms. Front Endocrinol (Lausanne). 2020 Mar 24:11:125.
Zhu, B., et al. Human gut microbiome: the second genome of human body. Protein Cell. 2010 Aug;1(8):718-25.
Resources
Articles
Lee, David. Parkinson’s, autism spectrum disorder, and the gut-brain axis: A role for psychobiotics in ameliorating neurological symptoms from the gut. LifeSci Voice. 2 Jun 2022.